Technoeconomically Optimal & Environmentally Benign Pharmaceutical Manufacturing at High Process Mass Intensity (PMI)

Project Details

StatusActive
Effective start/end date1/09/2131/08/25

Funding

  • Astra Zeneca: £29,628.00